Starlake Bioscience Co Inc Zhaoqing Guangdong Total Assets
Starlake Bioscience Co Inc Zhaoqing Guangdong total assets. Based on the latest financial reports, Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) holds total assets worth CN¥17.39 Billion CNY (≈ $2.54 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Starlake Bioscience Co Inc Zhaoqing Guan worth for the company's overall valuation and market capitalisation.
Total Assets of Starlake Bioscience Co Inc Zhaoqing Guangdong (1994–2025)
Total assets of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1994 to 2025. This chart illustrates how Starlake Bioscience Co Inc Zhaoqing Guangdong's total assets have evolved over time, based on quarterly financial data. See Starlake Bioscience Co Inc Zhaoqing Guan (600866) share price today for real-time trading data and today's change.
Starlake Bioscience Co Inc Zhaoqing Guangdong - Asset Composition Analysis
Starlake Bioscience Co Inc Zhaoqing Guangdong Total Assets Breakdown (December 2025)
Starlake Bioscience Co Inc Zhaoqing Guangdong total assets breakdown as of December 2025. Starlake Bioscience Co Inc Zhaoqing Guangdong's total assets of CN¥17.39 Billion consist of 34.0% current assets and 66.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.7% |
| Accounts Receivable | CN¥625.62 Million | 3.6% |
| Inventory | CN¥2.21 Billion | 12.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥662.84 Million | 3.8% |
| Goodwill | CN¥29.32 Million | 0.2% |
Asset Composition Trend (1994–2025)
This chart illustrates how Starlake Bioscience Co Inc Zhaoqing Guangdong's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Starlake Bioscience Co Inc Zhaoqing Guan (600866) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Starlake Bioscience Co Inc Zhaoqing Guangdong's current assets represent 34.0% of total assets in 2025, a decrease from 46.3% in 1994.
- Cash Position: Cash and equivalents constituted 12.7% of total assets in 2025, up from 0.0% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is inventory at 12.8% of total assets.
Starlake Bioscience Co Inc Zhaoqing Guangdong Competitors by Total Assets
Key competitors of Starlake Bioscience Co Inc Zhaoqing Guangdong based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $10.03 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $752.18 Million |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Verona Pharma PLC ADR
NASDAQ:VRNA
|
USA | $572.87 Million |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
Starlake Bioscience Co Inc Zhaoqing Guangdong - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.97 | 1.14 | 1.48 |
| Quick Ratio | 0.49 | 0.75 | 0.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-175.68 Million | CN¥835.03 Million | CN¥274.86 Million |
Starlake Bioscience Co Inc Zhaoqing Guangdong - Advanced Valuation Insights
This section examines the relationship between Starlake Bioscience Co Inc Zhaoqing Guangdong's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.89 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 18.5% |
| Total Assets | CN¥17.24 Billion |
| Market Capitalization | $1.04 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Starlake Bioscience Co Inc Zhaoqing Guangdong's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Starlake Bioscience Co Inc Zhaoqing Guangdong's assets grew by 18.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Starlake Bioscience Co Inc Zhaoqing Guangdong (1994–2025)
The table below shows the annual total assets of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1994 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥17.24 Billion ≈ $2.52 Billion |
+18.49% |
| 2024-12-31 | CN¥14.55 Billion ≈ $2.13 Billion |
+1.15% |
| 2023-12-31 | CN¥14.38 Billion ≈ $2.10 Billion |
-10.09% |
| 2022-12-31 | CN¥16.00 Billion ≈ $2.34 Billion |
+546.83% |
| 2021-12-31 | CN¥2.47 Billion ≈ $361.93 Million |
+2.12% |
| 2020-12-31 | CN¥2.42 Billion ≈ $354.41 Million |
+14.45% |
| 2019-12-31 | CN¥2.12 Billion ≈ $309.67 Million |
+46.42% |
| 2018-12-31 | CN¥1.45 Billion ≈ $211.50 Million |
-0.23% |
| 2017-12-31 | CN¥1.45 Billion ≈ $211.99 Million |
-15.30% |
| 2016-12-31 | CN¥1.71 Billion ≈ $250.27 Million |
-7.25% |
| 2015-12-31 | CN¥1.84 Billion ≈ $269.83 Million |
-18.25% |
| 2014-12-31 | CN¥2.26 Billion ≈ $330.05 Million |
-13.37% |
| 2013-12-31 | CN¥2.60 Billion ≈ $381.01 Million |
-21.87% |
| 2012-12-31 | CN¥3.33 Billion ≈ $487.67 Million |
-2.62% |
| 2011-12-31 | CN¥3.42 Billion ≈ $500.81 Million |
+48.34% |
| 2010-12-31 | CN¥2.31 Billion ≈ $337.62 Million |
+54.06% |
| 2009-12-31 | CN¥1.50 Billion ≈ $219.15 Million |
+10.37% |
| 2008-12-31 | CN¥1.36 Billion ≈ $198.56 Million |
+0.56% |
| 2007-12-31 | CN¥1.35 Billion ≈ $197.45 Million |
-4.24% |
| 2006-12-31 | CN¥1.41 Billion ≈ $206.19 Million |
+3.27% |
| 2005-12-31 | CN¥1.36 Billion ≈ $199.66 Million |
+4.61% |
| 2004-12-31 | CN¥1.30 Billion ≈ $190.85 Million |
+11.34% |
| 2003-12-31 | CN¥1.17 Billion ≈ $171.41 Million |
+14.41% |
| 2002-12-31 | CN¥1.02 Billion ≈ $149.82 Million |
+2.22% |
| 2001-12-31 | CN¥1.00 Billion ≈ $146.56 Million |
-7.51% |
| 2000-12-31 | CN¥1.08 Billion ≈ $158.47 Million |
+27.80% |
| 1999-12-31 | CN¥847.38 Million ≈ $124.00 Million |
+38.06% |
| 1998-12-31 | CN¥613.79 Million ≈ $89.82 Million |
+20.14% |
| 1997-12-31 | CN¥510.92 Million ≈ $74.76 Million |
+32.59% |
| 1996-12-31 | CN¥385.33 Million ≈ $56.39 Million |
+7.24% |
| 1995-12-31 | CN¥359.32 Million ≈ $52.58 Million |
+11.34% |
| 1994-12-31 | CN¥322.72 Million ≈ $47.22 Million |
-- |
About Starlake Bioscience Co Inc Zhaoqing Guangdong
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and selling food additives, feed additives, pharmaceutical intermediates, active pharmaceutical ingredients, organic fertilizers, and bio-based new materials. It operates through three main business lines: food and feed additives, biochemical raw materials and pharmaceutical intermediates, and organic fertilizers. The com… Read more